Drugs / Xeruborbactam
Xeruborbactam
also known as
QPX7728 · QPX-7728 DISODIUM · QPX7728 sodium · Xeruborbactam Oral Prodrug · XERUBORBACTAM SODIUM
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07104162 | Sep 2025 → Sep 2026 | bacterial infectious disease | Qpex Biopharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT07083817 | Aug 2025 | — | Qpex Biopharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT06157242 | Nov 2024 → Mar 2025 | bacterial infectious disease | Qpex Biopharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT06547554 | Sep 2024 → Oct 2025 | bacterial infectious disease | Qpex Biopharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT06079775 | Jan 2024 → Jan 2025 | bacterial infectious disease | Qpex Biopharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT05072444 | Nov 2021 | bacterial infectious disease | Qpex Biopharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT04380207 | Nov 2020 → Aug 2022 | bacterial infectious disease | Qpex Biopharma, Inc. | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xeruborbactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07104162 ↗ |
| Known as | QPX-7728 DISODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4633785 ↗ |
| Known as | QPX7728 | “investigational broad-spectrum beta-lactamase inhibitor (BLI), xeruborbactam (QPX7728)” NCT07104162 ↗ |
| Known as | QPX7728 sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL4633785 ↗ |
| Known as | Xeruborbactam Oral Prodrug | “A Phase 1, Open-Label, Drug-drug Interaction, and Randomized, Double-blind, Controlled, Multiple-dose Pharmacokinetics and Safety Study of Xeruborbactam Oral Prodrug (QPX7831)...” NCT06079775 ↗ |
| Known as | XERUBORBACTAM SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4633785 ↗ |
| Action | Inhibit | “QPX7728 is an ultra-broad-spectrum beta-lactamase inhibitor” NCT04380207 ↗ |
| Modality | Small molecule | “a new boron-based beta-lactamase inhibitor” NCT06079775 ↗ |
| Route | Intravenous | “Intravenous (IV) QPX7728” NCT04380207 ↗ |